CBD Capital Group

About The Fund

CBD Capital Group is an investor primarily focused on the burgeoning cannabinoid market, particularly targeting mid-stage nutraceutical companies that are already generating profits. They specialize in acquiring and aiding the development of these businesses, with the aim of expediting their growth trajectory and paving the way for swifter liquidity events. By injecting capital, CBD Capital Group enables entrepreneurs in the space to scale their operations more effectively. Additionally, the firm provides valuable expert advice and operational resources to fine-tune the strategies and processes within these companies. Although their core interest lies within the cannabinoid-based nutraceutical sector, CBD Capital Group's investment interests also span various related industries, including Hardware and Manufacturing, Cannabis, Blockchain and Cryptos, and Healthcare and Wellness. This eclectic mix demonstrates an approach that values diversified yet interconnected sectors that have the potential to interface with their primary investment theme of cannabinoid products and technologies. Beyond the financial aspects, the group's involvement extends to strategic guidance that ensures the businesses they invest in not only grow financially but also improve their market positioning, product quality, and operational efficiencies. With their headquarters in San Diego, California, CBD Capital Group leverages its location and networks within one of the most dynamic economic regions in the U.S. to provide portfolio companies access to a wealth of opportunities and partnerships.